Oscar Health, Inc. OSCR
30.65 USD -2.53 (-7.63%)
At closeNov 6, 2026, 7:53 PM EST
30.58 -0.07 -0.23%
After hours · Nov 6, 7:53 PM ET
30.06 Day range 33.64
10.85 52-week range 35.19
- YTD
- +113.29%
- 1 year
- +85.08%
- Market cap
- 9.46B
- Revenue (ttm)
- 15.32B
- Profit margin
- 3.60%
- EPS (ttm)
- 2.25
- Shares out
- 273.47M
- P/E ratio
- 13.62
- Forward P/E
- 13.79
- YTD return
- +113.29%
- 1-year return
- +85.08%
- Volume
- 8.89M
- Avg volume
- 5.37M
- Open
- 32.89
- Previous close
- 33.18
- Day's range
- 30.06 – 33.64
- 52-week range
- 10.85 – 35.19
- Beta
- 2.49
- Analysts
- Hold
- Price target
- 36.40 (+18.8%)
- Earnings date
- Feb 9, 2027
5D +0.15 (+0.49%)
Key statistics
- Enterprise value
- 2.78B
- PEG ratio
- 0.00
- Price / sales
- 0.62
- Price / book
- 9.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 70.40%
- Free cash flow
- 692.53M
- Total cash
- 8.56B
- Total debt
- 482.10M
- Return on equity
- 34.26%
- Short % of float
- 7.24%
- 50-day average
- 31.83
- 200-day average
- 23.93
Analyst view
Consensus: hold
Hold
Price target (mean) 36.40 +18.8% upside
Now 30.65
- Target (low)
- 27.00
- Target (mean)
- 36.40
- Target (high)
- 49.00
Ratings (0m) 11 3 buy · 7 hold · 1 sell
- Strong buy3
- Buy0
- Hold7
- Sell0
- Strong sell1
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate -1.08.
Financials — quick view
OSCR Revenue — quarterly 5.14B
OSCR Net income — quarterly 167.28M
OSCR EPS — quarterly 0.54
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | -1.10 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | -0.14382 | 0.49 | +0.63 | +440.70% |
| Aug 6, 2026 | Jun 30, 2026 | 0.403 | 1.10 | +0.70 | +172.95% |
| May 6, 2026 | Mar 31, 2026 | 1.21 | 2.07 | +0.86 | +71.07% |
| Feb 10, 2026 | Dec 31, 2025 | -0.9214 | -1.24 | -0.32 | -34.58% |
| Nov 6, 2025 | Sep 30, 2025 | -0.55 | -0.53 | +0.02 | +3.64% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Piper Sandler | main | Overweight | Overweight |
| Oct 12, 2026 | UBS | main | Neutral | Neutral |
| Sep 18, 2026 | Raymond James | main | Outperform | Outperform |
| Sep 17, 2026 | B of A Securities | main | Underperform | Underperform |
| Sep 17, 2026 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Sep 17, 2026 | Barclays | main | Overweight | Overweight |
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- hioscar.com
News
What Oscar Health (OSCR) Said on Its Q3 Earnings Call 
OSCR Q3 Earnings Call Highlights Strong Outlook and Margin Gains 
Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45 
Oscar Health (OSCR) Reports Q3 Earnings: What Key Metrics Have to Say 
Oscar Health Q3 2026 Earnings Call Transcript 
Oscar Health, Inc. (OSCR) Beats Q3 Earnings and Revenue Estimates 
Oscar Health Raises FY2026 Sales Guidance from $18.700B-$19.000B to $19.000B-$19.300B vs $18.732B Est - Oscar Health Q3 EPS $0.49 Beats $(0.20) Estimate, Sales $5.139B Beat $4.723B Estimate
Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook 
Healthcare Stocks Bounce on Midterm Results. A Bull Market Case Is Developing.
Your note
Sign in to keep a note on OSCR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BERTOLINI MARK T | Chief Executive Officer | Sale | Jun 29, 2026 | 7,751,570 |
| BLACKLEY RICHARD SCOTT | Chief Financial Officer | Sale | Sep 2, 2026 | 1,102,360 |
| BOPITIYA RANMALI WOODY | Officer | Sale | Dec 1, 2024 | 241,488 |
| BOYD JEFFERY H | Director | Stock Award(Grant) | Jun 3, 2025 | 705,673 |
| KUSHNER JOSHUA | Officer, Director and Beneficial Owner | Purchase | Nov 20, 2024 | 0 |
| LIANG JANET | Officer | Sale | Sep 2, 2026 | 248,697 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 7.53% | 20,587,428 | 630.70M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 4.77% | 13,035,486 | 399.34M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 4.62% | 12,643,617 | 387.34M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.03% | 11,029,424 | 337.89M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.87% | 10,579,437 | 324.10M | Jun 29, 2026 |
| American Century Companies Inc | 3.31% | 9,055,242 | 277.41M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.78% | 7,599,713 | 232.82M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.30% | 6,283,032 | 192.48M | Sep 29, 2026 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2.17% | 5,944,429 | 182.11M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.01% | 5,490,151 | 168.19M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.16% | 3,163,647 | 96.92M | Jun 29, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.12% | 3,055,642 | 93.61M | Jun 29, 2026 |